Aleve Ads Cite Specific FDA Advisory Panel Opinions On Naproxen Safety
This article was originally published in The Pink Sheet Daily
Executive Summary
Bayer steers clear of directly implying FDA endorsement of naproxen's safety by referencing mainstream media reports on the committees' discussions about COX-2 inhibitors and NSAIDs.